FLOGENZIM IN COMPLEX TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
The purpose of this drug to patients with initial and moderate symptoms of BPH in combination with traditional etiopathogenetic therapy along with good tolerability Flogenzim put in a number of particular relevance of therapeutic and prophylactic use. The results obtained the efficiency and safety Flogenzima with BPH can be recommended for wider application in treatment of these patients.
Number of Views: 357
Related publications:
COMPARATIVE EVALUATION OF BLOOD COLLECTION TUBES AND EXTRACTION METHODS FOR CIRCULATING TUMOR DNA
INFLUENCE OF SEX HORMONE-BINDING GLOBULIN (SHBG) ON THE LEVEL OF FREE TESTOSTERONE FRACTION IN OLDER OVERWEIGHT MEN
ASSESSMENT OF THE PROBABILITY OF DEVELOPING CARDIORENAL SYNDROME TYPE 2 DEPENDING ON POTENTIAL BIOMARKERS IN PEDIATRIC PATIENTS
MORPHO-GENETIC VARIABILITY IN MYOCARDIAL TISSUE AFTER SEPTAL MYECTOMY IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A FOUR-CASE SERIES STUDY
CLINICAL EFFICACY OF SELECTIVE PLASMA FILTRATION (EVACLIO) IN CARDIOVASCULAR COMPLICATIONS: A CASE SERIES FROM THE HEART CENTER KAZAKHSTAN